Wille CK and Zhang X, Haws S, Denu J, Sridharan R. DOT1L is a barrier to histone acetylation during reprogramming to pluripotency. Sci Adv. 2023 doi: 10.1126/sciadv.adf3980. PMID: 37976354

Wille CK, Neumann EN, Deshpande AJ, Sridharan R. DOT1L interaction partner AF10 controls patterning of H3K79 methylation and RNA polymerase II to maintain cell identity. Stem Cell Reports. 2023 doi: 10.1016/j.stemcr.2023.10.017. PMID: 37995701

Wille CK, Sridharan R. Connecting the DOTs on Cell Identity. Front Cell Dev Biol. 2022 doi: 10.3389/fcell.2022.906713. PMID: 35733849

Wille CK, Sridharan R. DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome. Stem Cell Reports. 2022 doi: 10.1016/j.stemcr.2021.12.004. PMID: 34995500

Haws SA, Yu D, Ye C, Wille CK, Nguyen LC, Krautkramer KA, Tomasiewicz JL, Yang SE, Miller BR, Liu WH, Igarashi K, Sridharan R, Tu BP, Cryns VL, Lamming DW, Denu JM. Methyl-Metabolite Depletion Elicits Adaptive Responses to Support Heterochromatin Stability and Epigenetic Persistence. Mol Cell. 2020 doi: 10.1016/j.molcel.2020.03.004. PMID: 32208170

Hoebe E, Wille C, Hagemeier S, Kenney S, Greijer A, and Middeldorp J. Epstein-Barr virus gene BARF1 expression is regulated by the epithelial differentiation factor ΔNp63α in undifferentiated nasopharyngeal carcinoma. Cancers (Basel). 2018 doi: 10.3390/cancers10030076. PMID: 29562599

Wille CK, Li Y, Rui L, Johannsen EC, Kenney SC. Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency. J Virol. 2017 doi: 10.1128/JVI.01987-16. PMID: 28003489

Wille CK, Nawandar DM, Henning AN, Ma S, Oetting KM, Lee D, Lambert P, Johannsen EC, Kenney SC. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch. Proc Natl Acad Sci U S A. 2015 doi: 10.1073/pnas.1513432112. PMID: 26663912

Nawandar DM, Wang A, MakielskiK, Lee D, Ma S, Barlow E, Reusch J, Jiang R, Wille CK, Greenspan D, Greenspan JS, Mertz JE, Hutt-Fletcher L, Johannsen EC, Lambert PF, and Kenney SC. Differentiation-dependent KLF4 expression promotes lytic Epstein-Barr virus infection in epithelial cells. PLoS Pathog. 2015 doi: 10.1371/journal.ppat.1005195. PMID: 26431332

Wille CK, Nawandar DM, Panfil AR, Ko MM, Hagemeier SR, and Kenney SC. Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication. J Virol. 2013 doi: 10.1128/JVI.01790-12. PMID: 23135711

Hoebe EK, Wille C, Hopmans ES, Robinson AR, Middeldorp JM, Kenney SC, and Greijer AE. Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation. J Virol. 2012 doi: 10.1128/JVI.01161-12. PMID: 22896599

Robinson AR, Kwek SS, Hagemeier SR, Wille CK, and Kenney SC. 2011. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency. J Virol. 2011 doi: 10.1128/JVI.00569-11. PMID: 21697476